Home > Journals
    • FILTER YOUR SEARCH
    Speciality:
    More Specialities

    • Journals

    touchREVIEWS in Endocrinology and US Endocrinology are peer-reviewed, free-to-access, bi-annual, journals that aims to provide insightful and topical articles relevant to the day-to-day practice of busy physicians.

    The journals are of interest to physicians, healthcare professionals and researchers across Europe and the US, providing practical advice relevant to the clinical setting on diagnosis and treatment in endocrinology. touchREVIEWS in Endocrinology and US Endocrinology endeavour to support these professionals in continuously developing their knowledge, effectiveness and productivity.

    Latest issue Journal information Editorial Board Submit your article here Contact us

    Journals Content

    Diabetes
    Diabetes Mellitus of Pituitary Origin: A Case Report
    Mandeep Singla, Jaspreet Kaur Saini

    touchREVIEWS in Endocrinology. 2021;1(1):Online ahead of journal publication

    Acromegaly is a chronic, progressive disease characterized by an excess secretion of growth hormone, and consequently, increased circulating insulin-like growth factor 1 (IGF-1) levels. These patients typically exhibit acral and soft tissue overgrowth, headache, arthritis and visual disturbances. Impaired glucose tolerance and diabetes mellitus are also frequently associated with acromegaly.1 We describe a patient who […]

    Endocrine Oncology
    An Occult Leydig Cell Tumour in a Postmenopausal Woman Presenting with Alopecia and Hirsutism: A Case Report
    Shuann Shwana, Natasha Shrikrishnapalasuriyar, Win Yin

    European Endocrinology. 2021;17(1):Online ahead of journal publication

    Postmenopausal state is associated with changes in the hormonal milieu characterized by reduced oestrogen, increased gonadotrophins and a small increase in testosterone levels.1,2 As a result, it is not uncommon for women in postmenopausal age group to show mild increases in androgen-driven hair growth.3,4 However, rapidly progressive hirsutism, acne and male-pattern alopecia in women warrants a search […]

    Endocrine Oncology
    Organ-specific Adverse Events of Immune Checkpoint Inhibitor Therapy, with Special Reference to Endocrinopathies
    Annu Susan George, Cornelius J Fernandez, Dilip Eapen

    touchREVIEWS in Endocrinology. 2021;1(1):Online ahead of journal publication

    Immune checkpoints are small molecules that are present on the cell surface of T lymphocytes to regulate the immune response. While some of these molecules enhance the stimulatory signals, others boost the inhibitory signals to blunt the activity of T lymphocytes (intrinsic down-regulators of immunity).1 The stimulatory checkpoints include CD28 – a family of receptors […]

    Reproductive Endocrinology
    Clinical, Metabolic and Hormonal Profiles of Bangladeshi Adolescents with Polycystic Ovary Syndrome
    ABM Kamrul-Hasan, Fatema Tuz Zahura Aalpona, Shahjada Selim

    European Endocrinology. 2021;17(1):Online ahead of journal publication

    Polycystic ovary syndrome (PCOS) is a heterogeneous androgen-excess disorder that presents with different degrees of reproductive and metabolic dysfunctions; it is also associated with insulin resistance and metabolic syndrome.1 The global prevalence estimates of PCOS in women of reproductive age are highly variable, ranging from 5% to 18%.2 This could be due to the lack of a […]

    Endocrine Oncology
    Screening for Hereditary Pheochromocytoma in a Patient with Neurofibromatosis Type 1: A Case Report
    Inês Isabel Ferreira Barros, Fernando Manso, Ana Isabel Caldas e Silva

    touchREVIEWS in Endocrinology. 2021;1(1):Online ahead of journal publication

    Rare catecholamine-secreting tumours that arise from the adrenal medulla and sympathetic ganglia are referred to as pheochromocytomas (PHEO) and paragangliomas, respectively.1 The annual incidence of PHEO in general population is approximately 2–8 cases per million.2 The age onset is typically the fourth decade of life.3 It occurs in less than 0.2% of patients with hypertension.4–7 Symptoms are present in […]

    Diabetes
    Dapagliflozin as an Adjunct Therapy to Insulin in Patients with Type 1 Diabetes Mellitus: Efficacy and Safety of this Combination
    Johan H Jendle, Francisco Javier Ampudia-Blasco, Martin Fuchtenbusch

    touchREVIEWS in Endocrinology. 2021;17(1):Online ahead of journal publication

    The prevalence of diabetes type 1 (T1D) and type 2 (T2D) is increasing worldwide; the number of people with diabetes was 463 million in 2019, but it is estimated to reach 700 million by 2045.1 The incidence of T1D is increasing in most countries.1 Age- and sex-standardized incidence rates from 1998 to 2013 (up to 25 years) […]

    Liver Disorders
    Potential Role of Dexamphetamine in the Treatment of Non-alcoholic Fatty Liver Disease: Hopes and Pitfalls
    CS Gautam, Jatin Sharma, Mandeep Singla

    touchREVIEWS in Endocrinology. 2021;17(1):Online ahead of journal publication

    Non-alcoholic fatty liver disease (NAFLD) is the most frequent cause of chronic liver disease globally; it is histologically classified into non-alcoholic fatty liver (NAFL) and non-alcoholic steatohepatitis (NASH).1 NAFL is characterized by the presence of >5% of hepatic steatosis without evidence of hepatocellular injury in the form of hepatocyte ballooning. NASH is the advanced stage of […]

    Pituitary Disorders
    Case Report of a Rare Adrenocortical Oncocytoma Suspected to be an Adrenal Carcinoma
    Inês Isabel Ferreira Barros, Fernando Manso, Margarida Teixeira

    touchREVIEWS in Endocrinology. 2021;17(1):Online ahead of journal publication

    Oncocytomas are epithelial tumours composed of cells with eosinophilic, mitochondria-rich cytoplasm.1 They can occur in various organs, such as the kidneys, thyroid, pituitary gland, salivary glands and parathyroid glands. Rarely, it has been reported in the respiratory and gastrointestinal tracts.2–4 Adrenal oncocytomas are extremely rare, with nearly 200 published cases since Kakimoto et al. reported the first […]

    Diabetes
    The Role of Individualized Exercise Prescription in Type 2 Diabetes Mellitus Management
    John Doupis, Konstantinos Karras, Konstantinos Avramidis

    touchREVIEWS in Endocrinology. 2021;1(1):Online ahead of journal publication

    Diabetes mellitus is a chronic disease that affects many people around the world. Sedentary lifestyle is considered a main risk factor for type 2 diabetes mellitus (T2DM). As presented in this editorial, the advantages of activity in preventing and treating T2DM are widely recognized. Exercise training improves glycaemic control, body composition, cardiorespiratory wellness, physical functioning […]

    Copied to clipboard!
    accredited arrow-downarrow_leftarrow-right-bluearrow-right-dark-bluearrow-right-greyarrow-right-orangearrow-right-whitearrow-right-bluearrow-up-orangeavatarcalendarchevron-down consultant-pathologist-nurseconsultant-pathologistcrosscrossdownloademailexclaimationfeedbackfiltergraph-arrowinterviewslinkmdt_iconmenumore_dots nurse-consultantpadlock patient-advocate-pathologistpatient-consultantpatientperson pharmacist-nurseplay_buttonplay-colour-tmcplay-colourAsset 1podcastprinter scenerysearch share single-doctor social_facebooksocial_googleplussocial_instagramsocial_linkedin_altsocial_linkedin_altsocial_pinterestlogo-twitter-glyph-32social_youtubeshape-star (1)tick-bluetick-orangetick-whiteticktimetranscriptup-arrowwebinar Department Location NEW TMM Corporate Services Icons-07NEW TMM Corporate Services Icons-08NEW TMM Corporate Services Icons-09NEW TMM Corporate Services Icons-10NEW TMM Corporate Services Icons-11NEW TMM Corporate Services Icons-12Salary £ TMM-Corp-Site-Icons-01TMM-Corp-Site-Icons-02TMM-Corp-Site-Icons-03TMM-Corp-Site-Icons-04TMM-Corp-Site-Icons-05TMM-Corp-Site-Icons-06TMM-Corp-Site-Icons-07TMM-Corp-Site-Icons-08TMM-Corp-Site-Icons-09TMM-Corp-Site-Icons-10TMM-Corp-Site-Icons-11TMM-Corp-Site-Icons-12TMM-Corp-Site-Icons-13TMM-Corp-Site-Icons-14TMM-Corp-Site-Icons-15TMM-Corp-Site-Icons-16TMM-Corp-Site-Icons-17TMM-Corp-Site-Icons-18TMM-Corp-Site-Icons-19TMM-Corp-Site-Icons-20TMM-Corp-Site-Icons-21TMM-Corp-Site-Icons-22TMM-Corp-Site-Icons-23TMM-Corp-Site-Icons-24TMM-Corp-Site-Icons-25TMM-Corp-Site-Icons-26TMM-Corp-Site-Icons-27TMM-Corp-Site-Icons-28TMM-Corp-Site-Icons-29TMM-Corp-Site-Icons-30TMM-Corp-Site-Icons-31TMM-Corp-Site-Icons-32TMM-Corp-Site-Icons-33TMM-Corp-Site-Icons-34TMM-Corp-Site-Icons-35TMM-Corp-Site-Icons-36TMM-Corp-Site-Icons-37TMM-Corp-Site-Icons-38TMM-Corp-Site-Icons-39TMM-Corp-Site-Icons-40TMM-Corp-Site-Icons-41TMM-Corp-Site-Icons-42TMM-Corp-Site-Icons-43TMM-Corp-Site-Icons-44TMM-Corp-Site-Icons-45TMM-Corp-Site-Icons-46TMM-Corp-Site-Icons-47TMM-Corp-Site-Icons-48TMM-Corp-Site-Icons-49TMM-Corp-Site-Icons-50TMM-Corp-Site-Icons-51TMM-Corp-Site-Icons-52TMM-Corp-Site-Icons-53TMM-Corp-Site-Icons-54TMM-Corp-Site-Icons-55TMM-Corp-Site-Icons-56TMM-Corp-Site-Icons-57TMM-Corp-Site-Icons-58TMM-Corp-Site-Icons-59TMM-Corp-Site-Icons-60TMM-Corp-Site-Icons-61TMM-Corp-Site-Icons-62TMM-Corp-Site-Icons-63TMM-Corp-Site-Icons-64TMM-Corp-Site-Icons-65TMM-Corp-Site-Icons-66TMM-Corp-Site-Icons-67TMM-Corp-Site-Icons-68TMM-Corp-Site-Icons-69TMM-Corp-Site-Icons-70TMM-Corp-Site-Icons-71TMM-Corp-Site-Icons-72